VYOME HOLDINGS, INC. Debt Securities, Available-for-sale, Unrealized Loss
VYOME HOLDINGS, INC. (HIND) reported Debt Securities, Available-for-sale, Unrealized Loss of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2020-02-27
- VYOME HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2019 was $0.00.
- VYOME HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2018 was $0.00.
- VYOME HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2017 was $0.00.
- VYOME HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2016 was $0.00.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |